Weight loss injections may have a powerful anti-cancer effect, new research suggests. Experts already know that losing weight reduces the risk of cancer, but now they think weight-loss jabs may have a ...

A new study shows that people Zepbound lost about 50% more weight than those using Wegovy. It was the first head-to-head ...

After hundreds of patients were given the newer jab and typically lost a fifth of their body weight after 72 weeks ...

Findings showed a 13.6% reduction in body weight in the semaglutide 25mg group compared with a 2.2% reduction in the placebo group.

Last year, more than 16 million people googled 'semaglutide' - sold under the brand names Wegovy and Ozempic - as demand for ...

A separate glipron, which has the slightly-less-headache-inducing name "danuglipron," is currently being developed by Pfizer. Like orforglipron, it's a once-a-day weight management pill.

It's the drug's generic name, so it could eventually be marketed under a different brand name. The medication is a glucagon-like peptide-1 (GLP-1) agonist, much like the extremely popular semaglutide ...

Why traditional weight loss methods fail to deliver sustainable results—and how Success by Sesame aims to solve that. The science-backed rise of GLP-1 medications and the role of compounded ...

A US judge on Thursday rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk's popular diabetes and weight-loss drugs Ozempic ... active ingredient, semaglutide. Compounders ...

Novo Nordisk sells semaglutide under the brands ... The latter, which sells tirzepatide under the brand names Zepbound and Mounjaro for weight loss and type 2 diabetes, respectively, claims ...

Novo Nordisk sells semaglutide under the brands Wegovy and Ozempic ... The latter, which sells tirzepatide under the brand names Zepbound and Mounjaro for weight loss and type 2 diabetes, respectively ...